← All diseases
Cancer
Lung cancer (non-small cell)
Do you want to receive a message when there is new research on Lung cancer (non-small cell)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research about Lung cancer (non-small cell) is available. View what Premium costs.
Publications and studies (3237)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence. (2023/12/01) ♡
- The Prognostic Nutritional Index before durvalumab after chemoradiation predict the overall survival in patients with stage III non-small cell lung cancer. (2023/12/01) ♡
- Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non-small cell lung cancer patients with neoadjuvant immunotherapy. (2023/12/01) ♡
- Identifying genes associated with resistance to KRAS G12C inhibitors via machine learning methods. (2023/12/01) ♡
- Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC). (2023/12/01) ♡
- Association of plasma branched-chain amino acid with multiple cancers: A mendelian randomization analysis. (2023/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. First-line immunotherapy in non-small cell lung cancer: how to select and where to go. (2023/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Recurrence-Free Survival for One Year after Surgery, Radiotherapy, and Chemotherapy for Stage Ⅳ Lung Cancer]. (2023/12/01) ♡
- [Interest of focal radiotherapy in case of oligoprogression under immunotherapy in the treatment of metastatic non-small cell lung cancer]. (2023/12/01) ♡
- Comprehensive sampling of the lung microbiome in early-stage non-small cell lung cancer. (2023/11/30) ♡
- Network pharmacology‑based investigation of potential targets of triptonodiol acting on non-small-cell lung cancer. (2023/11/28) ♡
- Inhibiting G6PD by quercetin promotes degradation of EGFR T790M mutation. (2023/11/28) ♡
- The Perceived Value of Liquid Biopsy: Results From a Canadian Validation Study of Circulating Tumor DNA T790M Testing-Patient's Willingness-to-Pay: A Brief Report. (2023/11/28) ♡
- Treatment pattern and outcomes of leptomeningeal carcinomatosis in India - a retrospective study. (2023/11/27) ♡
- Comprehensive value implications of surgeon volume for lung cancer surgery: Use of an analytic framework within a regional health system. (2023/11/24) ♡
- Lobe-specific lymph node sampling is associated with lower risk of cancer recurrence. (2023/11/23) ♡
- Real-World Data on Treatment Outcome of ALK-Positive Non-Small Cell Lung Cancer from an Indian Multicentric Cancer Registry. (2023/11/21) ♡
- LCMR1 Promotes Large-Cell Lung Cancer Proliferation and Metastasis by Downregulating HLA-Encoding Genes. (2023/11/16) ♡
- A quantitative evaluation method utilizing the homology concept to assess the state of chromatin within the nucleus of lung cancer. (2023/11/09) ♡
- Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer. (2023/11/03) ♡
- Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience. (2023/11/02) ♡
- Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib. (2023/11/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The negative effect of concomitant medications on immunotherapy in non-small cell lung cancer: An umbrella review. (2023/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The DC-T cell axis is an effective target for the treatment of non-small cell lung cancer. (2023/11/01) ♡
- A Biodegradable Nucleotide Coordination Polymer for Enhanced NSCLC Therapy in Combination with Metabolic Modulation. (2023/11/01) ♡
- Association between adherence to Eat-Lancet diet and incidence and mortality of lung cancer: A prospective cohort study. (2023/11/01) ♡
- A qualitative stakeholder analysis of beliefs, facilitators, and barriers for a feasible prehabilitation program before lung cancer surgery. (2023/11/01) ♡
- Glucose restriction induces AMPK-SIRT1-mediated circadian clock gene Per expression and delays NSCLC progression. (2023/11/01) ♡
- Discussion to: Comprehensive sampling of the lung microbiome in early-stage non-small cell lung cancer. (2023/10/30) ♡
- Efficacy and safety of utidelone for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer who have failed standard second-line treatment: A phase 2 clinical trial (BG01-1801). (2023/10/29) ♡
- Effects of omega-3 fatty acid supplementation on nutritional status and inflammatory response in patients with stage II-III NSCLC undergoing postoperative chemotherapy: a double-blind randomized controlled trial. (2023/10/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer. (2023/10/24) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis. (2023/10/23) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Acupuncture or moxibustion adjuvant chemotherapy for advanced non-small cell lung cancer: Systematic review and network meta-analysis. (2023/10/20) ♡
- Large-scale exome array summary statistics resources for glycemic traits to aid effector gene prioritization. (2023/10/20) ♡
- Detection of Tumor DNA in Bronchoscopic Fluids in Peripheral NSCLC: A Proof-of-Concept Study. (2023/10/19) ♡
- Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study. (2023/10/13) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis. (2023/10/11) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Real-world challenges in first-line treatment of metastatic EGFR-mutated non-small cell lung cancer. (2023/10/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunotherapy in Non-small Cell Lung Cancer: a Review. (2023/10/11) ♡
- Preconditioning program reduces the incidence of prolonged hospital stay after lung cancer surgery: Results from the Move For Surgery randomized clinical trial. (2023/10/10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia. (2023/10/10) ♡
- Cucurbitacin E Exerts Anti-Proliferative Activity via Promoting p62-Dependent Apoptosis in Human Non-Small-Cell Lung Cancer A549 Cells. (2023/10/07) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy and safety of Xiao-ai-ping injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: A systematic review and meta-analysis. (2023/10/06) ♡
- Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathway. (2023/10/05) ♡
- Immune checkpoint inhibitors for RET fusion non-small cell lung cancer: hopes and challenges. (2023/10/01) ♡
- USP12 promotes nonsmall cell lung cancer progression through deubiquitinating and stabilizing RRM2. (2023/10/01) ♡
- Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma. (2023/10/01) ♡
- Blocking LTB (4) signaling-mediated TAMs recruitment by Rhizoma Coptidis sensitizes lung cancer to immunotherapy. (2023/10/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Effects of exercise prehabilitation and/or rehabilitation on health-related quality of life and fatigue in patients with non-small cell lung cancer undergoing surgery: A systematic review. (2023/10/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.